. Sopan Pharmaceuticals is going to issue initial public offering (IPO) to the general public from April 15.

The company has been allowed to issue 42,90,000 units of shares worth Rs 42.90 crore i.e. 25% of the issued capital of Rs 1.71 billion. Out of this, 10 percent of the total 429,000 units of shares have been issued for the Nepalese employed abroad. The company has allotted 1,71,600 units of shares to the employees of the company and 2,14,500 units to the mutual funds.

In the second phase, the company is issuing 34,74,900 units of shares worth Rs 34,74,90,000 to the general public.

Applications can be place for minimum 10 units and maximum 11,000 units. Applications can be made from April 15 to April 20. NMB Capital has been appointed as the issue manager for the IPO issuance. The investors can apply for the shares from the Securities Board of Nepal (SEBON) through the banks and financial institutions that are members of the company.